AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
Number of shares outstanding for AVEO Oncology (AVEO)
Number of shares outstanding as of April 2024 : 34,618,000
According to AVEO Oncology 's latest financial reports and stock price the company's current number of shares outstanding is 34,618,000. At the end of 2022 the company had 34,618,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AVEO Oncology from 2009 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 34.61 M | 0.68% |
| 2021 | 34.38 M | 30.98% |
| 2020 | 26.25 M | -83.67% |
| 2019 | 0.16 B | 29.24% |
| 2018 | 0.12 B | 5.13% |
| 2017 | 0.11 B | 55.97% |
| 2016 | 75.86 M | 33.58% |
| 2015 | 56.79 M | 9.64% |
| 2014 | 51.8 M | 0.7% |
| 2013 | 51.44 M | 18.3% |
| 2012 | 43.48 M | 1.09% |
| 2011 | 43.01 M | 39.26% |
| 2010 | 30.88 M | 1817.38% |
| 2009 | 1.61 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 949,379,000 | 2,642.44% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 1,445.44% | 🇺🇸 USA |
 Biogen BIIB | 145,200,000 | 319.43% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 106,300,000 | 207.07% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 5,743.78% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | 14,321,000 | -58.63% | 🇺🇸 USA |